Skip to main content
Premium Trial:

Request an Annual Quote

Circular Genomics MindLight

Circular Genomics has launched MindLight, a circular RNA biomarker PCR blood test that predicts whether a patient with depression will respond to selective serotonin reuptake inhibitor (SSRI) treatment. According to the company, the test has a prognostic accuracy of 77 percent compared to standard first-line therapy response rates of 40 percent to 50 percent seen in clinical trials with SSRIs.